Intense remodeling of extracellular matrix within the varicose vein: the role of gelatinases and vascular endothelial growth factor

[1]  R. Karam,et al.  Clinical significance of plasma MMP‐2 and MMP‐9 levels as biomarkers for tumor expression in breast cancer patients in Egypt , 2019, Molecular Biology Reports.

[2]  M. E. Alvarez-Sánchez,et al.  Role of Matrix Metalloproteinases in Angiogenesis and Cancer , 2019, Front. Oncol..

[3]  A. Leite-Moreira,et al.  The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease. , 2018, Annals of Vascular Surgery.

[4]  S. Bae,et al.  Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9 , 2017, BMB reports.

[5]  G. Caimi,et al.  Gelatinases and physical exercise , 2017, Medicine.

[6]  J. Humphrey,et al.  Aging, Smooth Muscle Vitality, and Aortic Integrity , 2017, Circulation research.

[7]  M. Jahangiri,et al.  Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins , 2016, Cardiovascular research.

[8]  R. Khalil,et al.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[9]  Michael Simons,et al.  Endothelial cell metabolism in normal and diseased vasculature. , 2015, Circulation research.

[10]  G. Shi,et al.  Vascular wall extracellular matrix proteins and vascular diseases. , 2014, Biochimica et biophysica acta.

[11]  T. Wilgus,et al.  Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. , 2014, Advances in wound care.

[12]  E. Koczy-Baron,et al.  [The role of vascular endothelial growth factor in inflammatory processes]. , 2014, Postepy higieny i medycyny doswiadczalnej.

[13]  G. Opdenakker,et al.  Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy , 2013, PloS one.

[14]  R. Serra,et al.  Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  R. Khalil,et al.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. , 2013, Current drug targets.

[16]  J. de Haro,et al.  Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency , 2013, Phlebology.

[17]  R. Khalil,et al.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. , 2012, Experientia supplementum.

[18]  K. Sobolewski,et al.  Vascular endothelial growth factor and its receptors in the varicose vein wall , 2011 .

[19]  A. Stepulak,et al.  [Matrix metalloproteinases and atherosclerosis]. , 2011, Postepy higieny i medycyny doswiadczalnej.

[20]  A. Davies,et al.  Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. , 2010, Journal of vascular surgery.

[21]  S. Huh,et al.  The Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in the Wall of Great Saphenous Vein in Patients with Varicose Veins , 2010 .

[22]  Ying Lin,et al.  In vitro differences between smooth muscle cells derived from varicose veins and normal veins. , 2009, Journal of vascular surgery.

[23]  M. Droździk,et al.  Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins , 2009, Clinical and experimental dermatology.

[24]  L. Kraiss,et al.  Metalloproteinase expression in venous aneurysms. , 2008, Journal of vascular surgery.

[25]  J. Raffetto,et al.  Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins. , 2008, Journal of vascular surgery.

[26]  J. Raffetto,et al.  Mechanisms of varicose vein formation: valve dysfunction and wall dilation , 2008, Phlebology.

[27]  J. Raffetto,et al.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. , 2008, Biochemical pharmacology.

[28]  G. Godeau,et al.  Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? , 2007, Clinical science.

[29]  G. Moneta,et al.  Revision of the CEAP classification for chronic venous disorders: consensus statement. , 2004, Journal of vascular surgery.

[30]  K. Sobolewski,et al.  Matrix metalloproteinases in the vein wall. , 2004, International angiology : a journal of the International Union of Angiology.

[31]  S. Barker,et al.  Primary varicose veins: elevated plasma levels of the soluble isoform of the VEGF receptor flt-1 (s.flt-1) , 2005 .

[32]  G. Hunter,et al.  Morphologic characteristics of varicose veins: possible role of metalloproteinases. , 2003, Journal of vascular surgery.

[33]  Yohu Watanabe,et al.  Matrix Metalloproteinase-9 and Urokinase-type Plasminogen Activator in Varicose Veins , 1999, Annals of vascular surgery.

[34]  M. Jacob,et al.  Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation , 2000, The Journal of pathology.

[35]  J. Freischlag,et al.  Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. , 1998, Journal of vascular surgery.